From The Alzheimer's Association International Conference 2020: The Impact Of COVID-19 And The Global Pandemic On Alzheimer's Research
From The Alzheimer's Association International Conference 2020: The Impact Of COVID-19 And The Global Pandemic On Alzheimer's Research, Long-Term Care And The Brain
PR84947
CHICAGO, July 30, 2020 /PRNewswire=KYODO JBN/ --
COVID-19 and the global pandemic have caused significant disruption to all
aspects of life including Alzheimer's clinical research worldwide. The impact
of COVID, quarantine, and the resulting fear and isolation are causing
problems, but also driving unprecedented innovation. Yet the urgency to make
scientific advances in Alzheimer's and other dementia is so high that we must
look at how we can safely resume, continue and even accelerate clinical
research. The environment we are in is allowing us to establish creative and
innovative ways to safely move some studies forward.
Logo - https://mma.prnewswire.com/media/1219566/AAIC_2020_Logo.jpg
According to the Alzheimer's Association, U.S., long-term care facilities,
their staff and residents are experiencing a crisis due to a lack of
transparency, and an inability to access the necessary testing, accurate data
and information. According to some estimates, more than 59,000 residents and
workers have died from the coronavirus at nursing homes and other long-term
care communities. The Alzheimer's Association is advocating for important and
accessible changes, through policy recommendations (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=341237523&u=https%3A%2F%2Fwww.alz.org%2Fget-involved-now%2Fadvocate%2Fcoronavirus-(covid-19)-recommendations-policy&a=policy+recommendations ),
to help families as well as professional care providers.
A robust discussion at the Alzheimer's Association International
Conference(R)(AAIC(R)) (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=1756009977&u=https%3A%2F%2Fwww.alz.org%2Faaic%2Foverview.asp&a=Alzheimer%27s+Association+International+Conference )
2020 included experts from the Alzheimer's Association, University of Kentucky
College of Medicine, Rush University Medical Center and University of Texas
Health San Antonio discussing their professional experiences and viewpoints on
these evolving, provocative topics:
-- The impact of the pandemic on Alzheimer's research trials.
-- What we know about the impact of coronavirus on the brain and cognition.
-- The devastating effects on people with dementia in residential care
facilities, and the Alzheimer's Association's long-term care policy recommendations.
-- Health disparities the pandemic is putting in high relief, that also
strongly impact people with dementia and their families.
There was an announcement from the Alzheimer's Association of a new research
to globally track and understand the long-term impact of exposure to the
novel coronavirus on the brain.
"The Alzheimer's Association is proud to announce the launch of a new
international research study to globally track and understand the long-term
impact of exposure to the novel coronavirus on the brain, including cognition,
behavior and function," said Maria C. Carrillo, Ph.D., Alzheimer's Association
chief science officer. "Scientists from more than 30 countries are eager to
participate, and the World Health Organization is providing technical
assistance as we move this important collaboration forward. To build a strong
foundation for this research, we will align with existing studies-such as the
Framingham Heart Study-and clinicians from around the world on how the data is
measured and collected. To better understand the impact of the virus on the
brain, we will consider cross-study collaborations."
Additional quotes from Maria C. Carrillo, Ph.D., Alzheimer's Association chief
science officer
"Most likely, dementia does not increase risk for COVID-19, just like dementia
does not increase risk for the flu. However, dementia-related behaviors,
difficulty following safety protocols, increased age and common health
conditions that often accompany dementia may increase risk."
"There are the range of behavioral, social, biological and environmental
factors that influence health status. The following determinants are
heightening the impact of the COVID-19 crisis:
-- Lack of access to stable housing, transportation, and health-enhancing
resources may make it difficult to follow the necessary precautions to
prevent contracting COVID-19 or to seek treatment if they get sick.
-- Types of work, as well as the policies of work environments, can influence
risk for COVID-19. Workers without paid leave might be more likely to
continue working when they are sick. This can increase exposure to
COVID-19 or expose others to the virus.
-- Lack of access to insurance, and affordable health care."
"The COVID-19 pandemic continues to create additional challenges for people
living with Alzheimer's and all dementia, their families and caregivers.
Long-term care settings are especially impacted. According to some estimates,
more than 59,000 residents and workers have died from the coronavirus at
nursing homes and other long-term care communities. The Alzheimer's Association
is urging state and federal policymakers to implement new policy solutions that
will address the immediate and long-term issues impacting care facilities
during the COVID-19 pandemic."
The Impact of COVID-19 and the Global Pandemic on Alzheimer's Research,
Long-Term Care and the Brain: A panel discussion at AAIC 2020 for journalists
about COVID-19, the global pandemic, and its impact on Alzheimer's and other
dementia. The event featured:
-- Maria C. Carrillo, Ph.D., Chief Science Officer, Alzheimer's Association.
-- Gregory A. Jicha, M.D., Ph.D., University of Kentucky College of Medicine.
Director, Alzheimer's Disease Center Clinical Trials Unit; Associate
Director & Clinical Core Director, UK Alzheimer's Disease Center.
-- Neelum T. Aggarwal, M.D., Senior Neurologist, Rush Alzheimer's Disease
Center Clinical Core; Research Director, Rush Heart Center for Women at
Rush University Medical Center.
-- Beth Kallmyer, M.S.W., Vice President, Care and Support, Alzheimer's
Association.
-- Gabriel A. de Erausquin, M.D., Ph.D., M.Sc., Long School of Medicine, UT
Health San Antonio. Zachry Foundation Distinguished Professor of Neurology,
The Glenn Biggs Institute of Alzheimer's & Neurodegenerative Disorders.
Links to COVID-19-related Resources from the Alzheimer's Association
-- COVID-19 resources page (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=3727997879&u=https%3A%2F%2Fwww.alz.org%2Falzheimers-dementia%2Fcoronavirus-covid-19&a=COVID-19+resources+page )
-- COVID-19 tips for dementia caregivers (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=3303606461&u=https%3A%2F%2Falz.org%2Fhelp-support%2Fcaregiving%2Fcoronavirus-(covid-19)-tips-for-dementia-care&a=COVID-19+tips+for+dementia+caregivers )
-- Recommendations for protecting people in long-term care settings (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=4033433383&u=https%3A%2F%2Fwww.alz.org%2Fget-involved-now%2Fadvocate%2Fcoronavirus-(covid-19)-recommendations-policy&a=Recommendations+for+protecting+people+in+long-term+care+settings )
-- COVID-19: health disparities exposed (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=3533530072&u=https%3A%2F%2Fwww.alz.org%2Faaic%2Fdownloads2020%2FDI_HealthDisparities_Covid.pdf&a=COVID-19%3A+health+disparities+exposed )
-- Webinars for researchers: COVID-19 impact (https://c212.net/c/link/?t=0&l=en&o=2870440-1&h=3947980370&u=https%3A%2F%2Fwww.alz.org%2Fresearch%2Ffor_researchers%2Fgrants%2Fmedsci-webinars%2Fon-demand-research-webinars&a=Webinars+for+researchers%3A+COVID-19+impact )
The Alzheimer's Association International Conference (AAIC) is the world's
largest gathering of researchers from around the world focused on Alzheimer's
and other dementias. As a part of the Alzheimer's Association's research
program, AAIC serves as a catalyst for generating new knowledge about dementia
and fostering a vital, collegial research community.
AAIC 2020 home page: www.alz.org/aaic/
AAIC 2020 newsroom: www.alz.org/aaic/pressroom.asp
AAIC 2020 hashtag: #AAIC20
The Alzheimer's Association leads the way to end Alzheimer's and all other
dementia-by accelerating global research, driving risk reduction and early
detection, and maximizing quality care and support. Our vision is a world
without Alzheimer's and all other dementia. Visit www.alz.org or call the 24/7
Helpline at +1 800.272.3900.
SOURCE: Alzheimer's Association
CONTACT: Alzheimer's Association Media Line, +1 312-335-4078, media@alz.org;
AAIC 2020 Press Office, aaicmedia@alz.org
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。